Formulary Search
Search Results : Chronic Kidney Disease (Finerenone - Chronic Kidney Disease)
Show Icon and Status Keys
- Tablets
Stage 3 and 4, associated with Type 2 diabetes as per NICE TA877
Specialist teams should prescribe for at least 12 weeks to enable appropriate dose titrations and stabilisation of treatment prior to transfer of care.
Primary Care prescribing may be suitable following initiation by a specialist renal centre, locally those centres are Epsom & St Helier, Frimley or Brighton hospitals.
- Tablets
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to dapagliflozin initiation.
- Tablets
Dapagliflozin is the preferred SGLT-2 for CKD.
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to Empagliflozin initiation.
- Tablets
Hyperphosphataemia in patients with chronic renal failure
Hyperphosphataemia in patients with chronic renal failure - On recommendation from a specialist renal centre, locally those centres are Epsom & St Helier, Frimley or Brighton.
- Injection
Pruritus (associated with chronic kidney disease in patients on haemodialysis)
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.
- Injection
Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.